|
MK-8666
|
DB14937 |
[MK-8666 is under investigation in clinical trial NCT01971554 (Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)).] |
|
Picloxydine
|
DB13607 |
|
|
Tiocarlide
|
DB13608 |
|
|
Umifenovir
|
DB13609 |
|
|
Motixafortide
|
DB14939 |
[Motixafortide is under investigation in clinical trial NCT01838395 (Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients).] |
|
Promegestone
|
DB13602 |
|
|
GDC-0927
|
DB14934 |
[GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).] |
|
Nicotinamide riboside
|
DB14933 |
[Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).] |
|
Pyrrolnitrin
|
DB13603 |
|
|
Menaquinone 6
|
DB14936 |
[Menaquinone 6 is under investigation in clinical trial NCT01194778 (Comparison of Efficacy of Different Dosages Vitamin K2).] |
|
Guanazodine
|
DB13604 |
|
|
Phenoperidine
|
DB13605 |
|
|
Serabelisib
|
DB14935 |
[Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants).] |
|
Alovudine F-18
|
DB14930 |
[Alovudine F-18 is under investigation in clinical trial NCT02819024 (Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography).] |
|
Coleneuramide
|
DB14932 |
[Coleneuramide is under investigation in clinical trial NCT00307749 (Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy).] |
|
Deltamethrin
|
DB13600 |
|
|
Oxiracetam
|
DB13601 |
|
|
Cobomarsen
|
DB14931 |
[Cobomarsen is under investigation in clinical trial NCT02580552 (Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL).] |
|
Etoricoxib
|
DB01628 |
[Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.] |
|
Lincomycin
|
DB01627 |
[An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.] |
